Association of pre-existing comorbidities with outcome of allogeneic hematopoietic cell transplantation. A retrospective analysis from the EBMT

Risk assessment of allogeneic hematopoietic cell transplantation (allo-HCT) is hindered by the lack of current data on comorbidities and outcome. The EBMT identified 38,760 allo-HCT recipients with hematologic malignancies transplanted between 2010 and 2018 from matched sibling and unrelated donors...

Descripción completa

Detalles Bibliográficos
Autores principales: Penack, Olaf, Peczynski, Christophe, Mohty, Mohamad, Yakoub-Agha, Ibrahim, de la Camara, Rafael, Glass, Bertram, Duarte, Rafael F., Kröger, Nicolaus, Schoemans, Hélène, Koenecke, Christian, Peric, Zinaida, Basak, Grzegorz W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821004/
https://www.ncbi.nlm.nih.gov/pubmed/34718346
http://dx.doi.org/10.1038/s41409-021-01502-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821004/
https://www.ncbi.nlm.nih.gov/pubmed/34718346
http://dx.doi.org/10.1038/s41409-021-01502-8

Ejemplares similares